|
1
|
Wang ET, Sandberg R, Luo S, Khrebtukova I,
Zhang L, Mayr C, Kingsmore SF, Schroth GP and Burge CB: Alternative
isoform regulation in human tissue transcriptomes. Nature.
456:470–476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baralle F and Giudice J: Alternative
splicing as a regulator of development and tissue identity. Nat Rev
Mol Cell Biol. 18:437–451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson JM, Castle J, Garrett-Engele P,
Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R and
Shoemaker DD: Genome-wide survey of human alternative pre-mRNA
splicing with exon junction microarrays. Science. 302:2141–2144.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scotti MM and Swanson MS: RNA mis-splicing
in disease. Nat Rev Genet. 17:19–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J and Manley JL: Misregulation of
pre-mRNA alternative splicing in cancer. Cancer Discov.
3:1228–1237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J and Weiss WA: Alternative splicing
in cancer: Implications for biology and therapy. Oncogene. 34:1–14.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oltean S and Bates DO: Hallmarks of
alternative splicing in cancer. Oncogene. 33:5311–5318. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Z, Licklider LJ, Gygi SP and Reed R:
Comprehensive proteomic analysis of the human spliceosome. Nature.
419:182–185. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alzhanova-Ericsson AT, Sun X, Visa N,
Kiseleva E, Wurtz T and Daneholt B: A protein of the SR family of
splicing factors binds extensively to exonic Balbiani ring pre-mRNA
and accompanies the RNA from the gene to the nuclear pore. Genes
Dev. 10:2881–2893. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shepard PJ and Hertel KJ: The SR protein
family. Genome Biol. 10:2422009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de la Mata M and Kornblihtt AR: RNA
polymerase II C-terminal domain mediates regulation of alternative
splicing by SRp20. Nat Struct Mol Biol. 13:973–980. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fontrodona N, Aubé F, Claude JB, Polvèche
H, Lemaire S, Tranchevent LC, Modolo L, Mortreux F, Bourgeois CF
and Auboeuf D: Interplay between coding and exonic splicing
regulatory sequences. Genome Res. 29:711–722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao W, Adhikari S, Dahal U, Chen YS, Hao
YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, et al: Nuclear m(6)A
reader YTHDC1 regulates mRNA splicing. Mol Cell. 61:507–519. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye F, Chen ER and Nilsen TW: Kaposi's
sarcoma-associated herpesvirus utilizes and manipulates RNA N
6-adenosine methylation to promote lytic replication. J
Virol. 91:e00466–e00417. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corbo C, Orru S and Salvatore F: SRp20: An
overview of its role in human diseases. Biochem Biophys Res Commun.
436:1–5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brady LK, Wang H, Radens CM, Bi Y,
Radovich M, Maity A, CIvan C, Ivan M, Barash Y and Koumenis C:
Transcriptome analysis of hypoxic cancer cells uncovers intron
retention in EIF2B5 as a mechanism to inhibit translation. PLoS
Biol. 15:e20026232017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brugiolo M, Botti V, Liu N,
Müller-McNicoll M and Neugebauer KM: Fractionation iCLIP detects
persistent SR protein binding to conserved, retained introns in
chromatin, nucleoplasm and cytoplasm. Nucleic Acids Res.
45:10452–10465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sen S, Langiewicz M, Jumaa H and Webster
NJ: Deletion of serine/arginine-rich splicing factor 3 in
hepatocytes predisposes to hepatocellular carcinoma in mice.
Hepatology. 61:171–183. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ratnadiwakara M, Archer SK, Dent CI, Mozos
IR, Beilharz TH, Knaupp AS, Nefzger CM, Polo JM and Anko ML: SRSF3
promotes pluripotency through Nanog mRNA export and coordination of
the pluripotency gene expression program. Elife. 7:e374192018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jumaa H, Wei G and Nielsen PJ: Blastocyst
formation is blocked in mouse embryos lacking the splicing factor
SRp20. Curr Biol. 9:899–902. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kurokawa K, Akaike Y, Masuda K, Kuwano Y,
Nishida K, Yamagishi N, Kajita K, Tanahashi T and Rokutan K:
Downregulation of serine/arginine-rich splicing factor 3 induces G1
cell cycle arrest and apoptosis in colon cancer cells. Oncogene.
33:1407–1417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yea S, Narla G, Zhao X, Garg R, Tal-Kremer
S, Hod E, Villanueva A, Loke J, Tarocchi M, Akita K, et al: Ras
promotes growth by alternative splicing-mediated inactivation of
the KLF6 tumor suppressor in hepatocellular carcinoma.
Gastroenterology. 134:1521–1531. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia R, Zhang S, Liu M, Zhang Y, Liu Y, Fan
M and Guo J: HnRNP L is important for the expression of oncogene
SRSF3 and oncogenic potential of oral squamous cell carcinoma
cells. Sci Rep. 6:359762016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jia R, Li C, McCoy JP, Deng CX and Zheng
ZM: SRp20 is a proto-oncogene critical for cell proliferation and
tumor induction and maintenance. Int J Biol Sci. 6:806–826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang Y, Horikawa I, Ajiro M, Robles AI,
Fujita K, Mondal AM, Stauffer JK, Zheng ZM and Harris CC:
Downregulation of splicing factor SRSF3 induces p53beta, an
alternatively spliced isoform of p53 that promotes cellular
senescence. Oncogene. 32:2792–2798. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karthikeyan C, Amawi H, Viana AG, Sanglard
L, Hussein N, Saddler M, Ashby CR Jr, Moorthy NS, Trivedi P and
Tiwari AK: lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit
growth of colon cancer cells via apoptosis and sub G1 cell cycle
arrest. Bioorg Med Chem Lett. 28:2244–2249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim WJ, Lee SJ, Choi YD and Moon SK:
Decursin inhibits growth of human bladder and colon cancer cells
via apoptosis, G1-phase cell cycle arrest and extracellular
signal-regulated kinase activation. Int J Mol Med. 25:635–641.
2010.PubMed/NCBI
|
|
28
|
Morley KL, Ferguson PJ and Koropatnick J:
Tangeretin and nobiletin induce G1 cell cycle arrest but not
apoptosis in human breast and colon cancer cells. Cancer Lett.
251:168–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim J, Park RY, Chen JK, Kim J, Jeong S
and Ohn T: Splicing factor SRSF3 represses the translation of
programmed cell death 4 mRNA by associating with the 5′-UTR region.
Cell Death Differ. 21:481–490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park WC, Kim HR, Kang DB, Ryu JS, Choi KH,
Lee GO, Yun KJ, Kim KY, Park R, Yoon KH, et al: Comparative
expression patterns and diagnostic efficacies of SR splicing
factors and HNRNPA1 in gastric and colorectal cancer. BMC Cancer.
16:3582016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bowler E, Porazinski S, Uzor S, Thibault
P, Durand M, Lapointe E, Rouschop KM, Hancock J, Wilson I and
Ladomery M: Hypoxia leads to significant changes in alternative
splicing and elevated expression of CLK splice factor kinases in
PC3 prostate cancer cells. BMC Cancer. 18:3552018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goncalves V, Matos P and Jordan P: The
beta-catenin/TCF4 pathway modifies alternative splicing through
modulation of SRp20 expression. RNA. 14:2538–2549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goncalves V, Matos P and Jordan P:
Antagonistic SR proteins regulate alternative splicing of
tumor-related Rac1b downstream of the PI3-kinase and wnt pathways.
Hum Mol Genet. 18:3696–3707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Corbo C, Orrù S, Gemei M, Noto RD,
Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD and Salvatore F:
Protein cross-talk in CD133+ colon cancer cells indicates
activation of the Wnt pathway and upregulation of SRp20 that is
potentially involved in tumorigenicity. Proteomics. 12:2045–2059.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong X, Xu C, Zhang Y, Li X, Wang B, Wang
F, Yang Q, Wang D, Wang X, Li S, et al: BRG1 variant rs1122608 on
chromosome 19p13.2 confers protection against stroke and regulates
expression of pre-mRNA-splicing factor SFRS3. Hum Genet.
133:499–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang W, Niu C, Fu RY and Peng ZY:
Mycobacterium tuberculosis H37Rv infection regulates alternative
splicing in macrophages. Bioengineered. 9:203–208. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu GY, Huang SM, Liu ST, Liu PY, Chou WY
and Lin WS: Caffeine induces tumor cytotoxicity via the regulation
of alternative splicing in subsets of cancer-associated genes. Int
J Biochem Cell Biol. 47:83–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang YL, Hsu YJ, Chen Y, Wang YW and
Huang SM: Theophylline exhibits anti-cancer activity via
suppressing SRSF3 in cervical and breast cancer cell lines.
Oncotarget. 8:101461–101474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu GY, Liu ST, Huang SM, Chang YL and Lin
WS: Multiple effects of digoxin on subsets of cancer-associated
genes through the alternative splicing pathway. Biochimie.
106:131–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu B, Anderson SL, Qiu J and Rubin BY:
Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA
in familial dysautonomia derived cells by suppressing expression of
SRSF3. FEBS J. 280:3632–3646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wong RW, Balachandran A, Ostrowski MA and
Cochrane A: Digoxin suppresses HIV-1 replication by altering viral
RNA processing. PLoS Pathog. 9:e10032412013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang H, Zhang S, Song T, Guan X, Zhang R
and Chen X: Trichostatin a protects dendritic cells against
oxygen-glucose deprivation via the SRSF3/PKM2/glycolytic pathway.
Front Pharmacol. 9:6122018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jumaa H, Guenet JL and Nielsen PJ:
Regulated expression and RNA processing of transcripts from the
Srp20 splicing factor gene during the cell cycle. Mol Cell Biol.
17:3116–3124. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jumaa H and Nielsen PJ: Regulation of
SRp20 exon 4 splicing. Biochim Biophys Acta. 1494:137–143. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jumaa H and Nielsen PJ: The splicing
factor SRp20 modifies splicing of its own mRNA and ASF/SF2
antagonizes this regulation. EMBO J. 16:5077–5085. 1997. View Article : Google Scholar
|
|
46
|
Guo J, Jia J and Jia R: PTBP1 and PTBP2
impaired autoregulation of SRSF3 in cancer cells. Sci Rep.
5:145482015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jimenez M, Urtasun R, Elizalde M, Azkona
M, Latasa MU, Uriarte I, Arechederra M, Alignani D, Bárcena-Varela
M, Álvarez-Sola G, et al: Splicing events in the control of genome
integrity: Role of SLU7 and truncated SRSF3 proteins. Nucleic Acids
Res. 47:3450–3466. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Elizalde M, Urtasun R, Azkona M, Latasa
MU, Goñi S, García-Irigoyen O, Uriarte I, Segura V, Collantes M,
Scala MD, et al: Splicing regulator SLU7 is essential for
maintaining liver homeostasis. J Clin Invest. 124:2909–2920. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chang YL, Liu ST, Wang YW, Lin WS and
Huang SM: Amiodarone promotes cancer cell death through elevated
truncated SRSF3 and downregulation of miR-224. Oncotarget.
9:13390–13406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kano S, Nishida K, Kurebe H, Nishiyama C,
Kita K, Akaike Y, Kajita K, Kurokawa K, Masuda K, Kuwano Y, et al:
Oxidative stress-inducible truncated serine/arginine-rich splicing
factor 3 regulates interleukin-8 production in human colon cancer
cells. Am J Physiol Cell Physiol. 306:C250–C262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Barbagallo D, Caponnetto A, Cirnigliaro M,
Brex D, Barbagallo C, D'Angeli F, Morrone A, Caltabiano R,
Barbagallo GM, Ragusa M, et al: CircSMARCA5 inhibits migration of
glioblastoma multiforme cells by regulating a molecular axis
involving splicing factors SRSF1/SRSF3/PTB. Int J Mol Sci.
19:4802018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Q, Chikina MD, Pincas H and Sealfon
SC: Homer1 alternative splicing is regulated by
gonadotropin-releasing hormone and modulates gonadotropin gene
expression. Mol Cell Biol. 34:1747–1756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Blaustein M, Pelisch F, Tanos T, Muñoz MJ,
Wengier D, Quadrana L, Sanford JR, Muschietti JP, Kornblihtt AR,
Cáceres JF, et al: Concerted regulation of nuclear and cytoplasmic
activities of SR proteins by AKT. Nat Struct Mol Biol.
12:1037–1044. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Walsh CM, Suchanek AL, Cyphert TJ, Kohan
AB, Szeszel-Fedorowicz W and Salati LM: Serine arginine splicing
factor 3 is involved in enhanced splicing of glucose-6-phosphate
dehydrogenase RNA in response to nutrients and hormones in liver. J
Biol Chem. 288:2816–2828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen D, Zhao Z, Chen L, Li Q, Zou J and
Liu S: PPM1G promotes the progression of hepatocellular carcinoma
via phosphorylation regulation of alternative splicing protein
SRSF3. Cell Death Dis. 12:7222021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dennison B, Larson ED, Fu R, Mo J and
Fantauzzo KA: Srsf3 mediates alternative RNA splicing downstream of
PDGFRα signaling in the facial mesenchyme. Development.
148:dev1994482021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Long Y, Sou WH, Yung KW, Liu H, Wan SW, Li
Q, Zeng C, Law CO, Chan GH, Lau TC and Ngo JC: Distinct mechanisms
govern the phosphorylation of different SR protein splicing
factors. J Biol Chem. 294:1312–1327. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen H, Gao F, He M, Ding XF, Wong AM, Sze
SC, Yu AC, Sun T, Chan AWH, Wang X and Wong N: Long-read RNA
sequencing identifies alternative splice variants in hepatocellular
carcinoma and tumor-specific isoforms. Hepatology. 70:1011–1025.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ajiro M, Jia R, Yang Y, Zhu J and Zheng Z:
A genome landscape of SRSF3-regulated splicing events and gene
expression in human osteosarcoma U2OS cells. Nucleic Acids Res.
44:1854–1870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhu S, Chen Z, Katsha A, Hong J, Belkhiri
A and El-Rifai W: Regulation of CD44E by DARPP-32-dependent
activation of SRp20 splicing factor in gastric tumorigenesis.
Oncogene. 35:1847–1856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kuranaga Y, Sugito N, Shinohara H, Tsujino
T, Taniguchi K, Komura K, Ito Y, Soga T and Akao Y: SRSF3, a
splicer of the PKM gene, regulates cell growth and maintenance of
cancer-specific energy metabolism in colon cancer cells. Int J Mol
Sci. 19:30122018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yang S, Jia R and Bian Z: SRSF5 functions
as a novel oncogenic splicing factor and is upregulated by oncogene
SRSF3 in oral squamous cell carcinoma. Biochim Biophys Acta Mol
Cell Res. 1865:1161–1172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Änkö ML, Müller-McNicoll M, Brandl H, Curk
T, Gorup C, Henry I, Ule J and Neugebauer KM: The RNA-binding
landscapes of two SR proteins reveal unique functions and binding
to diverse RNA classes. Genome Biol. 13:R172012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Peiqi L, Zhaozhong G, Yaotian Y, Jun J,
Jihua G and Rong J: Expression of SRSF3 is correlated with
carcinogenesis and progression of oral squamous cell carcinoma. Int
J Med Sci. 13:533–539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gautrey H, Jackson C, Dittrich AL, Browell
D, Lennard T and Tyson-Capper A: SRSF3 and hnRNP H1 regulate a
splicing hotspot of HER2 in breast cancer cells. RNA Biol.
12:1139–1151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jia R, Ajiro M, Yu L, McCoy P Jr and Zheng
ZM: Oncogenic splicing factor SRSF3 regulates ILF3 alternative
splicing to promote cancer cell proliferation and transformation.
RNA. 25:630–644. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Dewaele M, Tabaglio T, Willekens K, Bezzi
M, Teo SX, Low DH, Koh CM, Rambow F, Fiers M, Rogiers A, et al:
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs
tumor growth. J Clin Invest. 126:68–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
He X and Zhang P: Serine/arginine-rich
splicing factor 3 (SRSF3) regulates homologous
recombination-mediated DNA repair. Mol Cancer. 14:1582015.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kim HR, Hwang SJ, Shin CH, Choi KH, Ohn T
and Kim HH: SRSF3-regulated miR-132/212 controls cell migration and
invasion by targeting YAP1. Exp Cell Res. 358:161–170. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kim HR, Shin CH, Lee H, Choi KH, Nam DH,
Ohn T and Kim HH: MicroRNA-1908-5p contributes to the oncogenic
function of the splicing factor SRSF3. Oncotarget. 8:8342–8355.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Loomis RJ, Naoe Y, Parker JB, Savic V,
Bozovsky MR, Macfarlan T, Manley JL and Chakravarti D: Chromatin
binding of SRp20 and ASF/SF2 and dissociation from mitotic
chromosomes is modulated by histone H3 serine 10 phosphorylation.
Mol Cell. 33:450–461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Torres S, García-Palmero I, Marín-Vicente
C, Bartolomé RA, Calviño E, Fernández-Aceñero MJ and Casal JI:
Proteomic characterization of transcription and splicing factors
associated with a metastatic phenotype in colorectal cancer. J
Proteome Res. 17:252–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lin JC, Lee YC, Tan TH, Liang YC, Chuang
HC, Fann YC, Johnson KR and Lin YJ: RBM4-SRSF3-MAP4K4 splicing
cascade modulates the metastatic signature of colorectal cancer
cell. Biochim Biophys Acta Mol Cell Res. 1865:259–272. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Buoso E, Ronfani M, Galasso M, Ventura D,
Corsini E and Racchi M: Cortisol-induced SRSF3 expression promotes
GR splicing, RACK1 expression and breast cancer cells migration.
Pharmacol Res. 143:17–26. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Buoso E, Galasso M, Ronfani M, Serafini
MM, Lanni C, Corsini E and Racchi M: Role of spliceosome proteins
in the regulation of glucocorticoid receptor isoforms by cortisol
and dehydroepiandrosterone. Pharmacol Res. 120:180–187. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ke H, Zhao L, Zhang H, Feng X, Xu H, Hao
J, Wang S, Yang Q, Zou L, Su X, et al: Loss of TDP43 inhibits
progression of triple-negative breast cancer in coordination with
SRSF3. Proc Natl Acad Sci USA. 115:E3426–E3435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
He X, Arslan AD, Pool MD, Ho TT, Darcy KM,
Coon JS and Beck WT: Knockdown of splicing factor SRp20 causes
apoptosis in ovarian cancer cells and its expression is associated
with malignancy of epithelial ovarian cancer. Oncogene. 30:356–365.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Park SK and Jeong S: SRSF3 represses the
expression of PDCD4 protein by coordinated regulation of
alternative splicing, export and translation. Biochem Biophys Res
Commun. 470:431–438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Shen T, Li H, Song Y, Li L, Lin J, Wei G
and Ni T: Alternative polyadenylation dependent function of
splicing factor SRSF3 contributes to cellular senescence. Aging
(Albany NY). 11:1356–1388. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Turnquist C, Horikawa I, Foran E, Major
EO, Vojtesek B, Lane DP, Lu X, Harris BT and Harris CC: p53
isoforms regulate astrocyte-mediated neuroprotection and
neurodegeneration. Cell Death Differ. 23:1515–1528. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Levy J, Towers C and Thorburn A: Targeting
autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhou L, Guo J and Jia R: Oncogene SRSF3
suppresses autophagy via inhibiting BECN1 expression. Biochem
Biophys Res Commun. 509:966–972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wee CD, Havens MA, Jodelka FM and Hastings
ML: Targeting SR proteins improves SMN expression in spinal
muscular atrophy cells. PLoS One. 9:e1152052014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yu Q, Guo J and Zhou J: A minimal length
between tau exon 10 and 11 is required for correct splicing of exon
10. J Neurochem. 90:164–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Rawcliffe DF, Österman L, Lindsten H and
Holmberg M: The high level of aberrant splicing of ISCU in
slow-twitch muscle may involve the splicing factor SRSF3. PLoS One.
11:e01654532016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sen S, Jumaa H and Webster NJ: Splicing
factor SRSF3 is crucial for hepatocyte differentiation and
metabolic function. Nat Commun. 4:13362013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Do DV, Strauss B, Cukuroglu E, Macaulay I,
Wee KB, Hu TX, Igor RD, Lee C, Harrison A, Butler R, et al: SRSF3
maintains transcriptome integrity in oocytes by regulation of
alternative splicing and transposable elements. Cell Discov.
4:332018. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Bedard KM, Daijogo S and Semler BL: A
nucleo-cytoplasmic SR protein functions in viral IRES-mediated
translation initiation. EMBO J. 26:459–467. 2007. View Article : Google Scholar
|
|
89
|
Mure F, Corbin A, Benbahouche NE, Bertrand
E, Manet E and Gruffat H: The splicing factor SRSF3 is functionally
connected to the nuclear RNA exosome for intronless mRNA decay. Sci
Rep. 8:129012018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ajiro M, Tang S, Doorbar J and Zheng ZM:
Serine/arginine-rich splicing factor 3 and heterogeneous nuclear
ribonucleoprotein A1 regulate alternative rna splicing and gene
expression of human papillomavirus 18 through two functionally
distinguishable cis elements. J Virol. 90:9138–9152. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Klymenko T, Hernandez-Lopez H, MacDonald
AI, Bodily JM and Graham SV: Human papillomavirus E2 regulates
SRSF3 (SRp20) to promote capsid protein expression in infected
differentiated keratinocytes. J Virol. 90:5047–5058. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Majerciak V, Lu M, Li X and Zheng ZM:
Attenuation of the suppressive activity of cellular splicing factor
SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is
required for RNA splicing. RNA. 20:1747–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ortiz-Sánchez P, Villalba-Orero M,
López-Olañeta MM, Larrasa-Alonso J, Sánchez-Cabo F, Martí-Gómez C,
Camafeita E, Gómez-Salinero JM, Ramos-Hernández L, Nielsen PJ, et
al: Loss of SRSF3 in cardiomyocytes leads to decapping of
contraction-related mRNAs and severe systolic dysfunction. Circ
Res. 125:170–183. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Dumont A, Dumont L, Zhou D, Giguère H,
Pileggi C, Harper ME, Blondin DP, Scott MS and Auger-Messier M:
Cardiomyocyte-specific Srsf3 deletion reveals a mitochondrial
regulatory role. FASEB J. 35:e215442021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kim K, Nguyen TD, Li S and Nguyen TA:
SRSF3 recruits DROSHA to the basal junction of primary microRNAs.
RNA. 24:892–898. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Fernandez N, Cordiner RA, Young RS, Hug N,
Macias S and Cáceres JF: Genetic variation and RNA structure
regulate microRNA biogenesis. Nat Commun. 8:151142017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Huang Y, Gattoni R, Stévenin J and Steitz
JA: SR splicing factors serve as adapter proteins for TAP-dependent
mRNA export. Mol Cell. 11:837–843. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hautbergue GM, Hung ML, Golovanov AP, Lian
LY and Wilson SA: Mutually exclusive interactions drive handover of
mRNA from export adaptors to TAP. Proc Natl Acad Sci USA.
105:5154–5159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Escudero-Paunetto L, Li L, Hernandez FP
and Sandri-Goldin RM: SR proteins SRp20 and 9G8 contribute to
efficient export of herpes simplex virus 1 mRNAs. Virology.
401:155–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Huang Y and Steitz JA: Splicing factors
SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol
Cell. 7:899–905. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kasowitz SD, Ma J, Anderson SJ, Leu NA, Xu
Y, Gregory BD, Schultz RM and Wang PJ: Nuclear m6A reader YTHDC1
regulates alternative polyadenylation and splicing during mouse
oocyte development. PLoS Genet. 14:e10074122018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Roundtree IA, Luo GZ, Zhang Z, Wang X,
Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, et al: YTHDC1
mediates nuclear export of N6-methyladenosine methylated
mRNAs. Elife. 6:e313112017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Muller-McNicoll M, Botti V, de Jesus
Domingues AM, Brandl H, Schwich OD, Steiner MC, Curk T, Poser I,
Zarnack K and Neugebauer KM: SR proteins are NXF1 adaptors that
link alternative RNA processing to mRNA export. Genes Dev.
30:553–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Yoon SP, Kim HH, Kim J, Park RY and Ohn T:
Regulation of cellular RNA nano-particle assembly by splicing
factor SRp20. J Nanosci Nanotechnol. 13:184–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Lou H, Neugebauer KM, Gagel RF and Berget
SM: Regulation of alternative polyadenylation by U1 snRNPs and
SRp20. Mol Cell Biol. 18:4977–4985. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Boutej H, Rahimian R, Thammisetty SS,
Béland LC, Lalancette-Hébert M and Kriz J: Diverging mRNA and
protein networks in activated microglia reveal SRSF3 suppresses
translation of highly upregulated innate immune transcripts. Cell
Rep. 21:3220–3233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Jang HN, Lee M, Loh TJ, Choi SW, Oh HK,
Moon H, Cho S, Hong SE, Kim DH, Sheng Z, et al: Exon 9 skipping of
apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through
interaction with exon 8. Biochim Biophys Acta. 1839:25–32. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Stickeler E, Kittrell F, Medina D and
Berget SM: Stage-specific changes in SR splicing factors and
alternative splicing in mammary tumorigenesis. Oncogene.
18:3574–3578. 1999. View Article : Google Scholar : PubMed/NCBI
|
